Use of psoralen-coupled nucleotide primers for screening of COL4A5 mutations in Alport syndrome

Kidney International

Volumn 50, Issue 4, 1996, Pages 1363-1367

  Netzer, Kai Olaf ^a   Seibold, Stefan ^a   Gross, Oliver ^a   Lambrecht, Romy ^a   Weber, Manfred ^a,b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b KRANKENHAUS MERHEIM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PSORALEN;

ALPORT SYNDROME; ARTICLE; CASE REPORT; HUMAN; METHODOLOGY; MUTATION RATE; PRIORITY JOURNAL;

EID: 0029829195     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.450     Document Type: Article

References (17)

1. ALPORT AC: Hereditary familial congenital haemorrhagic nephritis. Br Med J 1:504-506, 1927
2. SHEFFIELD VC, COX DR, LERMAN LS, MYERS RM: Attachment of a 40-base-pair G+C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes. Proc Natl Acad Sci USA 86:232-236, 1989
3. ABRAMS ES, STANTON VP: Use of denaturing gradient gel electrophoresis to study conformational transitions in nucleic acids. Meth Enzymol 212:71-104, 1992
4. HIGUCHI M, KAZAZIAN HH, KASCH L, WARRENTC, MCGINNISS MJ, PHILLIPS JA, KASPER C: Molecular characterization of severe hemophilia A suggests that about half the mutations are not within the coding regions and splice junctions of the factor VIII gene. Proc Natl Acad Sci USA 88:7405-7409, 1991
5. COSTES B, GIRODON E, GHANEM N, CHASSIGNOL M, THUONG NT, DUPRET D, GOOSSENS M: Psoralen-modified oligonucleotide primers improve detection of mutations by denaturing gradient gel electrophoresis and provide an alternative to GC-clamping. Hum Mol Genet 2:393-397, 1993
6. NETZER KO, RENDERS L, ZHOU J, PULLING O, TRYGGVASON K, WEBER M: Deletions of the COL4A5 gene in patients with Alport syndrome. Kidney Int 42:1336-1344, 1992
7. NETZER KO, PULLIG O, FREI U, ZHOU J, TRYGGVASON K, WEBER M: COL4A5 splice site mutation and α5(IV) collagen mRNA in Alport syndrome. Kidney Int 43:486-492, 1993
8. FLINTER FA, ABBS S, BOBROW M: Localization of the gene for classic Alport's syndrome. Genomics 4:335-338, 1989
9. ZHOU J, BARKER DF, HOSTIKKA SL, GREGORY MC, ATKIN CL, TRYGGVASON K: Single base mutation in alpha 5(IV) collagen chain gene converting a conserved cysteine to serine in Alport syndrome. Genomics 9:10-18, 1991
10. ATKIN CL, GREGORY MC, BORDER WA: Alport syndrome, in Diseases of the Kidney, edited by SCHRIER RW, GOTTSCHALK CW, Boston. Little, Brown and Co., 1988, pp 617-641
11. NOMURA S, OSAWA G, SAI T, HARANO T, HARANO K: A splicing mutation in the alpha 5(IV) collagen gene of a family with Alport's syndrome. Kidney Int 43:1116-1124, 1993
12. KUNKEL LM, SMITH KD, BOYER SH, BORGAONKAR DS, WACHTEL SS, MILLER OJ, BREG WR: Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 74:1245-1248, 1977
13. BHAN P, MILLER PS: Photo crosslinking of psoralen-derivatized oligonucleoside methylphosphonates to single-stranded DNA. Bioconjug Chem 1:82-88, 1990
14. BARKER DF, HOSTIKKA SL, ZHOU J, CHOW LT, OLIPHANT AR, GERKEN SC, GREGORY MC, SKOLNICK MH, ATKIN CL, TRYGGVASON K: Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248:1224-1227, 1990
15. BOYE E, VETRIE D, FLINTER F, BUCKL B, PIHLAJANIEMI T, HAMALAINEN ER, MYERS JC: Major rearrangements in the alpha 5(IV) gene in three patients with Alport syndrome. Genomics 11:1125-1132, 1991
16. VETRIE D, BOYE E, FLINTER F, BOBROW M, HARRIS A: DNA rearrangements in the alpha 5(IV) collagen gene (COL4A5) of individuals with Alport syndrome: Further refinement using pulsed-field gel electrophoresis. Genomics 14:624-633, 1992
17. SMEETS HJM, MELENHORST JJ, LEMMINK HH, SCHRÖDER CH, NELEN MR, ZHOU J, BRUNNER HG: Mutations in the COL4A5 collagen gene leading to different types of Alport syndrome. Kidney Int 42:83-88, 1992